Rosina T Lis

Rosina T Lis

UNVERIFIED PROFILE

Are you Rosina T Lis?   Register this Author

Register author
Rosina T Lis

Rosina T Lis

Publications by authors named "Rosina T Lis"

Are you Rosina T Lis?   Register this Author

25Publications

1046Reads

10Profile Views

A Prospective Study of Aspirin Use and Prostate Cancer Risk by Status.

Cancer Epidemiol Biomarkers Prev 2018 10 14;27(10):1231-1233. Epub 2018 Aug 14.

National Cancer Institute, Division of Cancer Epidemiology and Genetics, Epidemiology and Biostatistics Program, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-18-0510DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170677PMC
October 2018

MYC Overexpression at the Protein and mRNA Level and Cancer Outcomes among Men Treated with Radical Prostatectomy for Prostate Cancer.

Cancer Epidemiol Biomarkers Prev 2018 02 15;27(2):201-207. Epub 2017 Nov 15.

Department of Oncologic Pathology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-17-0637DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831163PMC
February 2018

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

Proc Natl Acad Sci U S A 2017 06 13;114(26):E5207-E5215. Epub 2017 Jun 13.

Division of Molecular and Cellular Oncology, Department of Medical Oncology, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215;

View Article

Download full-text PDF

Source
http://www.pnas.org/lookup/doi/10.1073/pnas.1617467114
Publisher Site
http://dx.doi.org/10.1073/pnas.1617467114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495225PMC
June 2017

Expression Levels of DNA Damage Repair Proteins Are Associated With Overall Survival in Platinum-Treated Advanced Urothelial Carcinoma.

Clin Genitourin Cancer 2016 08 24;14(4):352-9. Epub 2015 Dec 24.

Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2015.12.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508512PMC
August 2016

Association of Prostate Cancer Risk Variants with TMPRSS2:ERG Status: Evidence for Distinct Molecular Subtypes.

Cancer Epidemiol Biomarkers Prev 2016 05 3;25(5):745-9. Epub 2016 Mar 3.

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-1078DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873420PMC
May 2016

The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer.

Prostate 2015 Jun 1;75(9):897-906. Epub 2015 Mar 1.

Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.22973DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424159PMC
June 2015

Integrative clinical genomics of advanced prostate cancer.

Cell 2015 May;161(5):1215-1228

Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2015.05.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484602PMC
May 2015

Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study.

J Clin Oncol 2014 Nov 13;32(33):3705-15. Epub 2014 Oct 13.

Mary-Ellen Taplin, Massimo Loda, Rosina T. Lis, Wanling Xie, Zhenyang Jiang, and Philip W. Kantoff, Dana-Farber Cancer Institute, Harvard Medical School; Glenn J. Bubley, Huihui Ye, and Steven P. Balk, Beth Israel Deaconess Medical Center; Jerome P. Richie, Massimo Loda, and Rosina T. Lis, Brigham and Women's Hospital, Boston, MA; Bruce Montgomery, Bruce L. Dalkin, Lawrence D. True, and Alvin M. Matsumoto, University of Washington; Brett T. Marck and Alvin M. Matsumoto, Geriatric Research, Education and Clinical Center, Veterans' Affairs Puget Sound Health Care System; Elahe A. Mostaghel and Peter S. Nelson, Fred Hutchinson Cancer Research Center, Seattle, WA; Christopher J. Logothetis, John W. Davis, and Patricia Troncoso, University of Texas MD Anderson Cancer Center, Houston, TX; Martin G. Sanda, Emory University School of Medicine, Atlanta, GA; Massimo Loda, King's College London, London, United Kingdom; Trevor M. Penning and Daniel Tamae, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; and Christopher M. Haqq, NamPhuong Tran, Weimin Peng, Thian Kheoh, and Arturo Molina, Janssen Research and Development, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.4578DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226804PMC
November 2014

Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancer.

Cancer Epidemiol Biomarkers Prev 2014 Oct 12;23(10):2027-31. Epub 2014 Jun 12.

Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts. Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-14-0020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184923PMC
October 2014

Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG.

J Natl Cancer Inst 2013 Dec 30;105(24):1881-90. Epub 2013 Nov 30.

Affiliations of authors: Department of Epidemiology (AP, AM, MF, REG, KLP, JRR, EJN, MJS, ELG, LAM) and Department of Nutrition (MJS, ELG), Harvard School of Public Health, Boston, MA; Channing Division of Network Medicine (AP, KLP, JRR, MJS, ELG, LAM) and Division of Preventive Medicine (HDS) , Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Pathology, Brigham and Women's Hospital, Boston, MA (RTL, ECS, ML); Center for Molecular Oncologic Pathology (RTL, RF, ECS, MF, SF, NEM, ML), Department of Radiation Oncology (NEM), and Lank Center for Genitourinary Oncology (PWK), Dana-Farber Cancer Institute, Boston, MA; University of Dublin, Trinity College, Dublin, Ireland (RF, SF); Pathology Unit, Addarii Institute, S. Orsola-Malpighi Hospital, Bologna, Italy (MF); Department of Medicine, McGill University, Montreal, QC, Canada (MP).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt332DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866157PMC
December 2013

Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study.

Cancer Epidemiol Biomarkers Prev 2013 Nov 27;22(11):1984-93. Epub 2013 Aug 27.

Authors' Affiliations: Departments of Nutrition, Epidemiology, and Biostatistics, Harvard School of Public Health; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School; Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital; Departments of Pathology and Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Molecular and Transplantation Pathology Laboratory, F. Addarii Institute of Oncology, University of Bologna, Bologna, Italy; Center of Public Health Sciences, University of Iceland, Reykjavik, Iceland; The Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia; Department of Pathology & Laboratory Medicine and Oncology, University of Calgary, Calgary, Alberta; and Departments of Medicine and Oncology, McGill University, Jewish General Hospital, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-0349DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818474PMC
November 2013